Publications

Showing 2 of 2 Publications

2025

P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
Metzner A, Oglesby A, O’Rourke A, Galai N, Karver T, Davis W, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y, Kerrigan D. P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.699. PMCID: PMC11779361, DOI: 10.1093/ofid/ofae631.699.
Peer-Reviewed Original Research
Concepts

2023

1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers
Davis W, Mantsios A, Metzner A, Talan A, Kwait J, Rodriguez H, Karver T, Barker S, Suarez A, Fernandez R, Rodriguez-Diaz C, Taggart T, Oglesby A, Garris C, Wohl D, Barrington C, Kerrigan D. 1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers. Open Forum Infectious Diseases 2023, 10: ofad500.1371. PMCID: PMC10677220, DOI: 10.1093/ofid/ofad500.1371.
Peer-Reviewed Original Research
Concepts

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply